MFDS — authorised 10 October 2014
- Marketing authorisation holder: HELSINN HLTHCARE
- Status: likely_approved
🇰🇷 Akynzeo in South Korea
MFDS authorised Akynzeo on 10 October 2014
Marketing authorisation
Akynzeo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Akynzeo approved in South Korea?
Yes. MFDS authorised it on 10 October 2014.
Who is the marketing authorisation holder for Akynzeo in South Korea?
HELSINN HLTHCARE holds the South Korean marketing authorisation.